A Prospective randomized study to compare haematological toxicities and response between two different chemotherapy regimens in chemoradiotherapy treatment of carcinoma of uterine cervix.
Phase 3
- Conditions
- Health Condition 1: C539- Malignant neoplasm of cervix uteri, unspecified
- Registration Number
- CTRI/2024/08/072198
- Lead Sponsor
- SRI VENKATESHWARA INSTITUTE OF MEDICAL SCIENCES
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1. Biopsy proven carcinoma cervix
2. Age group – 20 to 65 years
3. Stage of IIB to IV A carcinoma of cervix (Staging will be done according to International Federation of Gynecology and Obstetrics)
4. ECOG Performance score 0,1.
5. Patients who signed informed consent.
6. EBRT treatment under 3DCRT
Exclusion Criteria
1. Biopsy proven carcinoma cervix
2. Age group – 20 to 65 years
3. Stage of IIB to IV A carcinoma of cervix (Staging will be done according to International Federation of Gynecology and Obstetrics)
4. ECOG Performance score 0,1.
5. Patients who signed informed consent.
6. EBRT treatment under 3DCRT
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method